Nikkei Hits All-Time High, Catalyst Pharma Acquired for $4.1B, Major Crypto Sell-Off Underway

1. Japan's Nikkei index closed at its highest level ever, signaling strong bullish sentiment in the Asian markets.
2. Angelini Pharma is set to acquire Catalyst Pharmaceuticals in a $4.1 billion all-cash deal at $31.50 per share.
3. A wallet linked to Matrixport deposited $17.3 million worth of HYPE onto an exchange and began a major sell-off, creating potential downward pressure on the crypto asset.